1. Home
  2. EVH vs CDNA Comparison

EVH vs CDNA Comparison

Compare EVH & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVH
  • CDNA
  • Stock Information
  • Founded
  • EVH 2011
  • CDNA 1998
  • Country
  • EVH United States
  • CDNA United States
  • Employees
  • EVH N/A
  • CDNA N/A
  • Industry
  • EVH Other Consumer Services
  • CDNA Medical Specialities
  • Sector
  • EVH Consumer Discretionary
  • CDNA Health Care
  • Exchange
  • EVH Nasdaq
  • CDNA Nasdaq
  • Market Cap
  • EVH 1.2B
  • CDNA 1.1B
  • IPO Year
  • EVH 2015
  • CDNA 2014
  • Fundamental
  • Price
  • EVH $10.00
  • CDNA $21.44
  • Analyst Decision
  • EVH Strong Buy
  • CDNA Buy
  • Analyst Count
  • EVH 13
  • CDNA 8
  • Target Price
  • EVH $20.85
  • CDNA $26.43
  • AVG Volume (30 Days)
  • EVH 2.3M
  • CDNA 851.0K
  • Earning Date
  • EVH 02-20-2025
  • CDNA 02-26-2025
  • Dividend Yield
  • EVH N/A
  • CDNA N/A
  • EPS Growth
  • EVH N/A
  • CDNA N/A
  • EPS
  • EVH N/A
  • CDNA N/A
  • Revenue
  • EVH $2,464,254,000.00
  • CDNA $312,775,000.00
  • Revenue This Year
  • EVH $31.68
  • CDNA $19.85
  • Revenue Next Year
  • EVH $14.35
  • CDNA $11.34
  • P/E Ratio
  • EVH N/A
  • CDNA N/A
  • Revenue Growth
  • EVH 37.65
  • CDNA 5.26
  • 52 Week Low
  • EVH $9.88
  • CDNA $7.42
  • 52 Week High
  • EVH $35.00
  • CDNA $34.84
  • Technical
  • Relative Strength Index (RSI)
  • EVH 32.51
  • CDNA 43.79
  • Support Level
  • EVH $9.88
  • CDNA $21.09
  • Resistance Level
  • EVH $12.78
  • CDNA $25.95
  • Average True Range (ATR)
  • EVH 0.71
  • CDNA 1.61
  • MACD
  • EVH -0.02
  • CDNA 0.02
  • Stochastic Oscillator
  • EVH 3.71
  • CDNA 19.46

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

Share on Social Networks: